- Previous Close
1.3400 - Open
1.3400 - Bid 1.3000 x --
- Ask 1.3300 x --
- Day's Range
1.3000 - 1.3400 - 52 Week Range
1.3000 - 2.0200 - Volume
127,800 - Avg. Volume
160,887 - Market Cap (intraday)
5.415B - Beta (5Y Monthly) 0.27
- PE Ratio (TTM)
44.33 - EPS (TTM)
0.0300 - Earnings Date --
- Forward Dividend & Yield 0.05 (3.73%)
- Ex-Dividend Date Mar 18, 2025
- 1y Target Est
--
Chiang Mai Ram Medical Business Public Company Limited provides medical services in Thailand. The company offers medical services in the areas of internal medicine and subspecialties, cardiology, general practice, pediatric, orthopedic and general surgery, pediatric surgery, obstetrics-gynecology, radiology, dentistry, anesthetic, ENT, and eye; and operates sub-specialty clinics for urology, neurology, endocrinology, oncology, hematology, plastic surgery, GI tract, and dermatology, as well as infertile and gynecologic oncology clinics. It provides dental, X-ray, CT multislices, cardiac catheterization, gynecologic cancer, back pain, physical therapy, operating theatre, laboratory, real-time PCR, ambulance, and CRD and health check-up services; and insurance products. It operates a medical care center under the Lanna Hospital name. The company was founded in 1974 and is headquartered in Chiang Mai, Thailand. Chiang Mai Ram Medical Business Public Company Limited is a subsidiary of Vibhavadi Medical Center Public Company Limited.
www.lanna-hospital.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CMR.BK
View MorePerformance Overview: CMR.BK
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CMR.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CMR.BK
View MoreValuation Measures
Market Cap
5.46B
Enterprise Value
8.69B
Trailing P/E
44.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.03
Price/Book (mrq)
1.45
Enterprise Value/Revenue
1.64
Enterprise Value/EBITDA
8.99
Financial Highlights
Profitability and Income Statement
Profit Margin
2.44%
Return on Assets (ttm)
2.20%
Return on Equity (ttm)
3.80%
Revenue (ttm)
5.35B
Net Income Avi to Common (ttm)
130.51M
Diluted EPS (ttm)
0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
270.95M
Total Debt/Equity (mrq)
59.61%
Levered Free Cash Flow (ttm)
429.34M